Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 11-19 of 19 (Search time: 0.004 seconds).
previous
1
2
next
Item hits:
Preview
Issue Date
Title
Author(s)
2006
Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL
Ross, D.
;
Branford, S.
;
Moore, S.
;
Hughes, T.
2008
Current and emerging tests for the laboratory monitoring of chronic myeloid leukaemia and related disorders
Ross, D.
;
Hughes, T.
2010
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR
Ross, D.
;
Branford, S.
;
Seymour, J.
;
Schwarer, A.
;
Arthur, C.
;
Bartley, P.
;
Slader, C.
;
Field, C.
;
Dang, P.
;
Filshie, R.
;
Mills, A.
;
Grigg, A.
;
Vaz de Melo, J.
;
Hughes, T.
2011
Do we have to kill the last CML cell?
Ross, D.
;
Hughes, T.
;
Vaz de Melo, J.
2010
Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA
Bartley, P.
;
Ross, D.
;
Latham, S.
;
Martin-Harris, M.
;
Budgen, B.
;
Wilczek, V.
;
Branford, S.
;
Hughes, T.
;
Morley, A.
2012
BCR-ABL1 doubling times more reliably assess the dynamics of CML relapse compared with the BCR-ABL1 fold rise: implications for monitoring and management
Branford, S.
;
Yeung, D.
;
Prime, J.
;
Choi, S.
;
Bang, J.
;
Park, J.
;
Kim, D.
;
Ross, D.
;
Hughes, T.
2008
Reverse transcription with random pentadecamer primers improves the detection limit of a quantitative PCR assay for BCR-ABL transcripts in chronic myeloid leukemia: Implications for defining sensitivity in minimal residual disease
Ross, D.
;
Watkins, D.
;
Hughes, T.
;
Branford, S.
2013
Dasatinib targets chronic myeloid leukemia-CD34⁺ progenitors as effectively as it targets mature cells
Hiwase, D.
;
Saunders, V.
;
Nievergall, E.
;
Ross, D.
;
White, D.
;
Hughes, T.
2013
Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patients
Ross, D.
;
O'Hely, M.
;
Bartley, P.
;
Dang, P.
;
Score, J.
;
Goyne, J.
;
Sobrinho-Simoes, M.
;
Cross, N.
;
Melo, J.
;
Speed, T.
;
Hughes, T.
;
Morley, A.
Discover
Author
15
Branford, S.
8
Yeung, D.
6
Seymour, J.
5
Bartley, P.
5
Grigg, A.
5
White, D.
4
Arthur, C.
4
Braley, J.
4
Dang, P.
4
Filshie, R.
.
next >
Subject
6
Fusion Proteins, bcr-abl
6
Humans
5
Antineoplastic Agents
5
Leukemia, Myelogenous, Chronic, B...
5
Pyrimidines
4
Benzamides
4
chronic myeloid leukaemia
4
Piperazines
3
Imatinib Mesylate
3
Neoplasm, Residual
.
next >
Date issued
15
2010 - 2018
4
2006 - 2009